Integrative Network Pharmacology and Molecular Docking Analyses on the Mechanisms of San-Zhong-Kui-Jian-Tang in Treating Oral Squamous Cell Carcinoma

Abstract

Objective

Oral squamous cell carcinoma (OSCC) is an aggressive cancer with a high mortality rate. San-Zhong-Kui-Jian-Tang (SZKJT), a Chinese herbal formula, has long been used as an adjuvant therapy in cancer clinical practice. Although its therapeutic effects and molecular mechanisms in OSCC have been previously elucidated, the potential interactions and mechanisms between the active phytochemicals and their therapeutic targets are still lacking.

Methods

The present study employed network pharmacology and topology approaches to establish a “herbal ingredients–active phytochemicals–target interaction” network to explore the potential therapeutic targets of SZKJT-active phytochemicals in the treatment of OSCC. The role of the target proteins in oncogenesis was assessed via GO and KEGG enrichment analyses, and their interactions with the active phytochemicals of SZKJT were calculated via molecular docking and dynamic simulations. The pharmacokinetic properties and toxicity of the active phytochemicals were also predicted. 

Results

A total of 171 active phytochemicals of SZKJT fulfilled the bioavailability and drug-likeness screening criteria, with the flavonoids quercetin, kaempferol, and naringenin having the greatest potential. The 4 crucial targets of these active phytochemicals are PTGS2, TNF, BCL2, and CASP3, which encode cyclooxygenase-2, tumor necrosis factor (TNF), BCL-2 apoptosis regulator, and caspase-3, respectively. The interactions between phytochemicals and target proteins were predicted to be thermodynamically feasible and stable via molecular docking and dynamics simulations. Finally, the results revealed that the IL-6/JAK/STAT3 pathway and TNF signaling via NF-κB are the two prominent pathways targeted by SZKJT.

Conclusion

In summary, this study provides computational data for in-depth exploration of the mechanism by which SZKJT activates phytochemicals to treat OSCC.

Keywords

Binding interactions / Hub genes / In silico / Protein‒protein interaction network / Traditional Chinese medicine

References

[1] de ChauveronJ, UngerM, LescailleG, et al.. Artificial intelligence for oral squamous cell carcinoma detection based on oral photographs: A comprehensive literature review. Cancer Med., 2024, 13(1) ArticleID: e6822

[2] BrayF, LaversanneM, SungH, et al.. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca-Cancer J Clin., 2024, 74 3): 229-263

[3] World Health Organization. Oral health. 2025. Available from: https://www.who.int/news-room/fact-sheets/detail/oral-health.

[4] World Health Organization. Oral Health Malaysia 2022 country profile. 2022. Available from: https://www.who.int/publications/m/item/oral-health-mys-2022-country-profile.

[5] JustesenMM, StampeH, JakobsenKK, et al.. Impact of tumor subsite on survival outcomes in oral squamous cell carcinoma: A retrospective cohort study from 2000 to 2019. Oral Oncol., 2024, 149 ArticleID: 106684

[6] KendeP, MathurY, VarteV, et al.. The efficacy of neoadjuvant chemotherapy as compared to upfront surgery for the management of oral squamous cell carcinoma: a systematic review and meta-analysis. Int J Oral Surg., 2024, 53(1): 1-10

[7] XuH, ZhengC, ZhangZ, et al.. Tumor microenvironment-activatable nanocatalysts with chemodynamic therapy and enhanced autophagy for specific treatment of oral squamous cell carcinoma. Colloids Surf B., 2024, 236 ArticleID: 113713

[8] DawoodS, AustinL, CristofanilliM. Cancer stem cells: implications for cancer therapy. Oncology (Williston Park)., 2014, 28(12): 1101-1107

[9] XiangY, GuoZ, ZhuP, et al.. Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science. Cancer Med., 2019, 8(5): 1958-1975

[10] YadavN, DeshmukhR, MazumderR. A comprehensive review on the use of traditional Chinese medicine for cancer treatment. Pharmacological Research - Modern Chinese Medicine., 2024, 11, ArticleID: 100423

[11] WangM, ChenS, HeX, et al.. Targeting inflammation as cancer therapy. J Hematol Oncol., 2024, 17(1): 13

[12] LiY, PangB, HuaB, et al.. Discussion on the thinking of five elements of disease differentiation and infinite thinking of prescription methods based on the view of compound pathogenesis of malignant tumor. China J Tradit Chin Med Pharm., 2024, 39(11): 5762-5765

[13] WangJ, ZhangP, MiaoR, et al.. Exploring the Application of Regulating Tumor Immunity and Antitumor Metastasis by Invigorating Blood Method Based on the Theory of Qi Channels. J Tradit Chin Med., 2024, 65(20): 2163-2172

[14] LiuJ, WangS, ZhangY, et al.. Traditional Chinese medicine and cancer: History, present situation, and development. Thorac Cancer., 2015, 6(5): 561-569

[15] SoTH, ChanSK, LeeVHF, et al.. Chinese Medicine in Cancer Treatment; How is it Practiced in the East and the West?. Clin Oncol., 2019, 31(8): 578-588

[16] YangJ-f, PeiX-h. An Analysis of Li Dong-yuan's Academic Thought of Surgery and the Law of Treatment Based on Syndrome Differentiation in Secrets from the Orchid Chamber. Henan Tradit Chin Med., 2020, 40(3): 360-362

[17] HsuY-L, YenM-H, KuoP-L, et al.. San-Zhong-Kui-Jian-Tang, a traditional Chinese medicine prescription, inhibits the proliferation of human breast cancer cell by blocking cell cycle progression and inducing apoptosis. Biol Pharm Bull., 2006, 29(12): 2388-2394

[18] ChengCY, LinYH, SuCC. Anti-tumor activity of Sann-Joong-Kuey-Jian-Tang alone and in combination with 5-fluorouracil in a human colon cancer colo 205 cell xenograft model. Mol Med Rep., 2010, 3(2): 227-231

[19] ChengC-Y, LinY-H, SuC-C. Sann-Joong-Kuey-Jian-Tang increases the protein expression of microtubule-associated protein II light chain 3 in human colon cancer colo 205 cells. Mol Med Rep., 2009, 2(5): 707-711

[20] SuCC. Sann-Joong-Kuey-Jian-Tang decreases the protein expression of mammalian target of rapamycin but increases microtubule associated protein II light chain 3 expression to inhibit human BxPC-3 pancreatic carcinoma cells. Mol Med Rep., 2015, 11(4): 3160-3166

[21] ChuangWL, SuCC, LinPY, et al.. Sann-Joong-Kuey-Jian-Tang induces autophagy in HepG2 cells via regulation of the phosphoinositide-3 kinase/Akt/mammalian target of rapamycin and p38 mitogen-activated protein kinase pathways. Mol Med Rep., 2015, 12(2): 1677-1684

[22] HsuP-Y, ChenJ-L, KuoS-L, et al.. San-Zhong-Kui-Jian-Tang Exerts Antitumor Effects Associated With Decreased Cell Proliferation and Metastasis by Targeting ERK and the Epithelial-Mesenchymal Transition Pathway in Oral Cavity Squamous Cell Carcinoma. Integr Cancer Ther., 2022, 21: 15347354221134921

[23] WeiM, LiH, LiQ, et al.. Based on Network Pharmacology to Explore the Molecular Targets and Mechanisms of Gegen Qinlian Decoction for the Treatment of Ulcerative Colitis. BioMed Research International., 2020, 2020(1): 5217405

[24] HuW, FuW, WeiX, et al.. A Network Pharmacology Study on the Active Ingredients and Potential Targets of Tripterygium wilfordii Hook for Treatment of Rheumatoid Arthritis. J Evidence-Based Complementary Altern Med., 2019, 2019(1): 5276865

[25] LiuH, WangJ, ZhouW, et al.. Systems approaches and polypharmacology for drug discovery from herbal medicines: An example using licorice. J Ethnopharmacol., 2013, 146(3): 773-793

[26] BappyMNI, AhmedF, LaskerT, et al.. Screening of Novel Drug Targets and Drug Design for Bordetella pertussis: A Subtractive Proteomics Approach. Curr Res Microb Sci., 2024, 7 100291

[27] Tan CH, Lim SH, Sim KS. Computational Elucidation of Hub Genes and Pathways Correlated with the Development of 5-Fluorouracil Resistance in HCT 116 Colorectal Carcinoma Cell Line. Biochem Genet. 2025.

[28] XieZ, BaileyA, KuleshovMV, et al.. Gene Set Knowledge Discovery with Enrichr. Curr Protoc., 2021, 1(3) ArticleID: e90

[29] BugnonM, RöhrigUF, GoullieuxM, et al.. SwissDock 2024: major enhancements for small-molecule docking with Attracting Cavities and AutoDock Vina. Nucleic Acids Res., 2024, 52 W1): W324-W332

[30] TanCH, SimDSY, HengMP, et al.. Evaluation of DNA Binding and Topoisomerase I Inhibitory Activities of 16’‐Decarbomethoxydihydrovoacamine from Tabernaemontana corymbosa. ChemistrySelect., 2020, 5(47): 14839-14843

[31] Tan C-H, Yeap JS-Y, Lim S-H, et al. The Bisindole Alkaloids Angustilongines M and A from Alstonia penangiana Induce Mitochondrial Apoptosis and G0/G1 Cell Cycle Arrest in HT-29 Cells through Promotion of Tubulin Polymerization. J Nat Prod. 2021;84(5):1524–1533.

[32] Yap LX, Ramle AQ, Sim KS, et al. In Vitro and Computational Studies of Indoleninyl-Pyrimido[1,2-b]Indazoles as DNA Binding Agents. Natl Acad Sci Lett 2024.

[33] OngKK, RamleQA, NgMP, et al.. Computational and In vitro Elucidation of Indolenine-barbituric Acid Zwitterions as Potential Chemotherapeutical Agents. Lett Drug Des Discov., 2024, 21(15): 3076-3084

[34] Funmi AZ, Lim CY, Ng MP, et al. Investigation of cytotoxic indoleninyl-thiobarbiturate zwitterions as DNA targeting agents. J Mol Struct. 2024:140278.

[35] BasirNH, RamleAQ, NgMP, et al.. Discovery of indoleninyl-pyrazolo[3,4-b]pyridines as potent chemotherapeutic agents against colorectal cancer cells. Bioorg Chem., 2024, 146 ArticleID: 107256

[36] Hassan HA, Ramle AQ, Tan CH, et al. 2-hydroxylbenzoyl-pyrazolo[1,5-a]pyrimidines as inhibitors against bacterial pathogens and MCF7 human breast cancer cells. J Mol Struct. 2025:142278.

[37] TanCH, SimDSY, LimSH, et al.. Antiproliferative and Microtubule-stabilizing Activities of Two Iboga-vobasine Bisindoles Alkaloids from Tabernaemontana corymbosa in Colorectal Adenocarcinoma HT-29 Cells. Planta Med., 2022, 88(14): 1325-1340

[38] SzklarczykD, FranceschiniA, WyderS, et al.. STRING v10: protein–protein interaction networks, integrated over the tree of life. Nucleic Acids Res., 2014, 43(D1): D447-D452

[39] TruongJ, GeorgeA, HolienJK. Analysis of physicochemical properties of protein-protein interaction modulators suggests stronger alignment with the "rule of five". RSC Med Chem., 2021, 12(10): 1731-1749

[40] Çevik UA, Işik A, Karakaya A. ADMET and Physicochemical Assessments in Drug Design. In: Computational Methods for Rational Drug Design. Hoboken: John Wiley & Sons, Inc.; 2025. p:123–151.

[41] GamageDG, GunaratneA, PeriyannanGR, et al.. Applicability of instability index for in vitro protein stability prediction. Protein Pept Lett., 2019, 26(5): 339-347

[42] WeiF, KouroT, NakamuraY, et al.. Enhancing Mass spectrometry-based tumor immunopeptide identification: machine learning filter leveraging HLA binding affinity, aliphatic index and retention time deviation. Comput Struct Biotechnol J., 2024, 23: 859-869

[43] Sganzerla Martinez G, Dutt M, Kumar A, et al. Multiple Protein Profiler 1.0 (MPP): A Webserver for Predicting and Visualizing Physiochemical Properties of Proteins at the Proteome Level. Protein J. 2024;43(4):711–717.

[44] GaoT, GaoY, LiuX, et al.. Identification and functional analysis of the SARS-CoV-2 nucleocapsid protein. BMC Microbiol., 2021, 21(1): 58

[45] RamírezD, CaballeroJ. Is It Reliable to Take the Molecular Docking Top Scoring Position as the Best Solution without Considering Available Structural Data?. Molecules (Basel, Switzerland)., 2018, 23(5): 1038

[46] NguyenNT, NguyenTH, PhamTNH, et al.. Autodock Vina Adopts More Accurate Binding Poses but Autodock4 Forms Better Binding Affinity. J Chem Inf Model., 2020, 60(1): 204-211

[47] DaiY, HeX, ZhangY, et al.. Exploring the Mechanism of Curcumin-Mediated Photodynamic Therapy for Systemic Lupus Erythematosus Based on Network Pharmacology. J Herb Med, 2025, 49, ArticleID: 100972

[48] FatriansyahJF, BoanergesAG, KurniantoSR, et al.. Molecular Dynamics Simulation of Ligands from Anredera cordifolia (Binahong) to the Main Protease (M (pro) of SARS-CoV-2. J Trop Med., 2022, 2022: 1178228

[49] BerlinCB, SharmaE, KozlowskiMC. Quantification of Hydrogen-Bond-Donating Ability of Biologically Relevant Compounds. The Journal of Organic Chemistry., 2024, 89(7): 4684-4690

[50] Cofer-ShabicaDV, MengerMFSJ, OuQ, et al.. INAQS, a Generic Interface for Nonadiabatic QM/MM Dynamics: Design, Implementation, and Validation for GROMACS/Q-CHEM simulations. J Chem Theory Comput., 2022, 18(8): 4601-4614

[51] LipinskiCA, LombardoF, DominyBW, et al.. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev., 2001, 46(1–3): 3-26

[52] VeberDF, JohnsonSR, ChengHY, et al.. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem., 2002, 45(12): 2615-2623

[53] WaltersWP, MurckoMA. Prediction of 'drug-likeness'. Adv Drug Deliv Rev., 2002, 54(3): 255-271

[54] Morris-SchafferK, McCoyMJ. A Review of the LD50 and Its Current Role in Hazard Communication. ACS Chem Health Saf., 2021, 28(1): 25-33

[55] JiashuoW, ZhangF, LiZ, et al.. Integration strategy of network pharmacology in Traditional Chinese Medicine: a narrative review. J Tradit Chin Med., 2022, 42(3): 479

[56] LvM, DingR, MaP, et al.. Network Pharmacology Analysis on the Mechanism of Xihuangwan in Treating Rectal Cancer and Radiation Enteritis. Curr Pharm Des., 2024, 30(9): 683-701

[57] AguPC, AfiukwaCA, OrjiOU, et al.. Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management. Sci Rep., 2023, 13(1): 13398

[58] ShuklaR, TripathiT SinghDB. Molecular Dynamics Simulation of Protein and Protein-Ligand Complexes. Computer-Aided Drug Design, 2020 Singapore Springer Singapore 133-161

[59] ColottaF, AllavenaP, SicaA, et al.. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis., 2009, 30(7): 1073-1081

[60] GrivennikovSI, GretenFR, KarinM. Immunity, inflammation, and cancer. Cell., 2010, 140(6): 883-899

[61] RhodusNL, HoV, MillerCS, et al.. NF-κB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma. Cancer Detect Prev., 2005, 29(1): 42-45

[62] LotfiA, ShahidiN, BayazianG, et al.. Serum level of interleukin-6 in patients with oral tongue squamous cell carcinoma. Iranian journal of otorhinolaryngology., 2015, 27(80): 207

[63] LeeJJ, ChangYL, LaiWL, et al.. Increased prevalence of interleukin-17–producing CD4+ tumor infiltrating lymphocytes in human oral squamous cell carcinoma. Head Neck., 2011, 33(9): 1301-1308

[64] WenW, AlseekhS, FernieAR. Conservation and diversification of flavonoid metabolism in the plant kingdom. Curr Opin Plant Biol., 2020, 55: 100-108

[65] NabaviSM, ŠamecD, TomczykM, et al.. Flavonoid biosynthetic pathways in plants: Versatile targets for metabolic engineering. Biotechnol Adv., 2020, 38 ArticleID: 107316

[66] ZhangH-W, HuJ-J, FuR-Q, et al.. Flavonoids inhibit cell proliferation and induce apoptosis and autophagy through downregulation of PI3Kγ mediated PI3K/AKT/mTOR/p70S6K/ULK signaling pathway in human breast cancer cells. Sci Rep., 2018, 8(1): 11255

[67] LiskovaA, KoklesovaL, SamecM, et al.. Flavonoids in cancer metastasis. Cancers., 2020, 12(6): 1498

[68] GalluzzoP, MartiniC, BulzomiP, et al.. Quercetin-induced apoptotic cascade in cancer cells: Antioxidant versus estrogen receptor α-dependent mechanisms. Mol Nutr Food Res., 2009, 53(6): 699-708

[69] EzzatiM, YousefiB, VelaeiK, et al.. A review on anticancer properties of Quercetin in breast cancer. Life Sci., 2020, 248 ArticleID: 117463

[70] JanaN, BřetislavG, PavelS, et al.. Potential of the Flavonoid Quercetin to Prevent and Treat Cancer-Current Status of Research. Klin Onkol., 2018, 31(3): 184-190

[71] ChoiEJ, BaeSM, AhnWS. Antiproliferative effects of quercetin through cell cycle arrest and apoptosis in human breast cancer MDA-MB-453 cells. Arch Pharmacal Res., 2008, 31: 1281-1285

[72] Reyes-FariasM, Carrasco-PozoC. The Anti-Cancer Effect of Quercetin: Molecular Implications in Cancer Metabolism. Int J Mol Sci., 2019, 20(13): 3177

[73] ShafabakhshR, AsemiZ. Quercetin: a natural compound for ovarian cancer treatment. J Ovarian Res., 2019, 12(1): 55

[74] DowerJI, GeleijnseJM, GijsbersL, et al.. Supplementation of the pure flavonoids epicatechin and quercetin affects some biomarkers of endothelial dysfunction and inflammation in (pre) hypertensive adults: a randomized double-blind, placebo-controlled, crossover trial. J Nutr., 2015, 145(7): 1459-1463

[75] ImranM, SalehiB, Sharifi-RadJ, et al.. Kaempferol: A Key Emphasis to Its Anticancer Potential. Molecules (Basel, Switzerland)., 2019, 24(12): 2277

[76] LinC-W, ChenP-N, ChenM-K, et al.. Kaempferol Reduces Matrix Metalloproteinase-2 Expression by Down-Regulating ERK1/2 and the Activator Protein-1 Signaling Pathways in Oral Cancer Cells. PloS one., 2013, 8(11) ArticleID: e80883

[77] KangJW, KimJH, SongK, et al.. Kaempferol and quercetin, components of Ginkgo biloba extract (EGb 761), induce caspase‐3‐dependent apoptosis in oral cavity cancer cells. Phytother Res., 2010, 24 S1): S77-S82

[78] ZhangY, ChenAY, LiM, et al.. Ginkgo biloba extract kaempferol inhibits cell proliferation and induces apoptosis in pancreatic cancer cells. J Surg Res., 2008, 148(1): 17-23

[79] EeYY, HoongCC. Downregulation in the mRNA expression of nuclear hormone receptor liver-X-receptor alpha (LXR-α) by TNF-α is abolished by the antioxidant kaempferol, but not ascorbic acid, in human hepatocarcinoma HepG2 cells. Asian Biomed., 2012, 6(4): 585-589

[80] LuoH, RankinGO, LiuL, et al.. Kaempferol inhibits angiogenesis and VEGF expression through both HIF dependent and independent pathways in human ovarian cancer cells. Nutr Cancer., 2009, 61(4): 554-563

[81] LeeJ, KimJH. Kaempferol Inhibits Pancreatic Cancer Cell Growth and Migration through the Blockade of EGFR-Related Pathway In Vitro. PLoS one., 2016, 11(5) ArticleID: e0155264

[82] RaufA, ShariatiMA, ImranM, et al.. Comprehensive review on naringenin and naringin polyphenols as a potent anticancer agent. Environ Sci Pollut Res., 2022, 29 21): 31025-31041

[83] MotallebiM, BhiaM, RajaniHF, et al.. Naringenin: A potential flavonoid phytochemical for cancer therapy. Life Sci., 2022, 305 ArticleID: 120752

[84] ZengW, JinL, ZhangF, et al.. Naringenin as a potential immunomodulator in therapeutics. Pharmacol Res., 2018, 135: 122-126

[85] MaggioniD, NicoliniG, RigolioR, et al.. Myricetin and naringenin inhibit human squamous cell carcinoma proliferation and migration in vitro. Nutr Cancer., 2014, 66(7): 1257-1267

[86] TodoricJ, AntonucciL, KarinM. Targeting inflammation in cancer prevention and therapy. Cancer Prev Res., 2016, 9(12): 895-905

[87] RebelloCJ, BeylRA, LertoraJJL, et al.. Safety and pharmacokinetics of naringenin: A randomized, controlled, single-ascending-dose clinical trial. Diabetes, Obes Metab., 2020, 22(1): 91-98

[88] O’LearyKA, de Pascual-TereasaS, NeedsPW, et al.. Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription. Mutat Res, Fundam Mol Mech Mutagen., 2004, 551(1–2): 245-254

[89] KadiogluO, NassJ, SaeedME, et al.. Kaempferol is an anti-inflammatory compound with activity toward NF-κB pathway proteins. Anticancer Res., 2015, 35(5): 2645-2650

[90] KuriharaY, HatoriM, AndoY, et al.. Inhibition of cyclooxygenase-2 suppresses the invasiveness of oral squamous cell carcinoma cell lines via downregulation of matrix metalloproteinase-2 production and activation. Clinical & Experimental Metastasis., 2009, 26(5): 425-432

[91] SantoroA, BufoP, RussoG, et al.. Expression and clinical implication of cyclooxygenase-2 and E-cadherin in oral squamous cell carcinomas. Cancer Biol Ther., 2020, 21(8): 667-674

[92] Hashemi GoradelN, NajafiM, SalehiE, et al.. Cyclooxygenase-2 in cancer: A review. J Cell Physiol., 2019, 234(5): 5683-5699

[93] KuriharaY, HatoriM, AndoY, et al.. Inhibition of cyclooxygenase-2 suppresses the invasiveness of oral squamous cell carcinoma cell lines via downregulation of matrix metalloproteinase-2 production and activation. Clin Exp Metastasis., 2009, 26(5): 425-432

[94] KwakYE, JeonNK, KimJ, et al.. The Cyclooxygenase-2 Selective Inhibitor Celecoxib Suppresses Proliferation and Invasiveness in the Human Oral Squamous Carcinoma. Ann N Y Acad Sci., 2007, 1095(1): 99-112

[95] BournazouE, BrombergJ. Targeting the tumor microenvironment: JAK-STAT3 signaling. Jakstat., 2013, 2(2) e23828

[96] XiaoL, LiX, CaoP, et al.. Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway. J Exp Clin Cancer Res., 2022, 41 1): 166

[97] WeiL-Y, LinH-C, TsaiF-C, et al.. Effects of Interleukin-6 on STAT3-regulated signaling in oral cancer and as a prognosticator of patient survival. Oral Oncol., 2022, 124 ArticleID: 105665

[98] FangJ, ChuL, LiC, et al.. JAK2 inhibitor blocks the inflammation and growth of esophageal squamous cell carcinoma in vitro through the JAK/STAT3 pathway. Oncol Rep., 2015, 33(1): 494-502

[99] GlogauerJE, SunCX, BradleyG, et al.. Neutrophils increase oral squamous cell carcinoma invasion through an invadopodia-dependent pathway. Cancer Immunol Res., 2015, 3(11): 1218-1226

[100] GoertzenC, MahdiH, LaliberteC, et al.. Oral inflammation promotes oral squamous cell carcinoma invasion. Oncotarget., 2018, 9(49): 29047-29063

[101] MaQ, HaoS, HongW, et al.. Versatile function of NF-ĸB in inflammation and cancer. Exp Hematol Oncol., 2024, 13(1): 68

[102] HameedA, IjazS, MohammadIS, et al.. Aglycone solanidine and solasodine derivatives: A natural approach toward cancer. Biomed Pharmacother., 2017, 94: 446-457

RIGHTS & PERMISSIONS

The Author(s), under exclusive licence to Huazhong University of Science and Technology